Conversion from Tacrolimus to Sirolimus May Increase the Risk of Cardiovascular Events in Kidney Transplant Recipients.

被引：0
|
作者：
Kim, M. [1 ]
Pavlakis, M. [1 ]
Rogers, C. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [31] Cardiovascular Disease and Kidney Disease Progression in Kidney Transplant Recipients.
    John, A.
    Weiner, D.
    Carpenter, M.
    Hunsicker, L.
    Kusek, J.
    Pfeffer, M.
    Solomon, S.
    Weir, M.
    Levey, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 422 - 422
  • [32] SYSTEMIC IMMUNOREGULATORY EFFECTS OF TACROLIMUS TO SIROLIMUS CONVERSION IN LIVER TRANSPLANT RECIPIENTS
    Levitsky, Josh
    Miller, Joshua
    Tambur, Anat R.
    Abdul-Nabi, Anmaar
    Yang, Guang-Yu
    Chandrasekaran, Dhivya
    Herrera, Nancy
    Al-Saden, Patrice C.
    Mathew, James M.
    HEPATOLOGY, 2011, 54 : 637A - 637A
  • [33] Predictors of Cardiovascular Events in Adult Renal Transplant Recipients.
    Arlen, Dianne
    Cole, Edward
    Holland, David
    Jevnikar, Anthony
    Kim, Joseph
    Knoll, Greg
    Ross, Heather
    Zaltzman, Jeffrey
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 240 - 240
  • [34] Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients.
    Jeong, R.
    Quinn, R.
    Ravani, P.
    Lentine, K.
    Lloyd, A.
    Hemmelgarn, B.
    Wen, K.
    Braam, B.
    Gourishankar, S.
    Wong, A.
    Lam, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 807 - 807
  • [35] Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
    Efe, Orhan
    Al Jurdi, Ayman
    Eiting, Morgan Mabey
    Marks, Christine Rogers
    Cote, Mariesa Ann
    Wojciechowski, David
    Safa, Kassem
    Gilligan, Hannah
    Azzi, Jamil
    Goyal, Nitender
    Raynaud, Marc
    Loupy, Alexandre
    Weins, Astrid
    Riella, Leonardo V.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Conversion from Tacrolimus (TAC) to Sirolimus (SRL)-Based Immunosuppressive Regimen in Kidney Transplant Recipients: 1 Year Results
    Tedesco, H.
    Garcia, V.
    David-Neto, E.
    Contieri, F.
    Carvalho, D.
    Abbud, M.
    Ikehara, E.
    Alfieri, F.
    Medina-Pestana, J. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 299 - 299
  • [37] Conversion from Tacrolimus (TAC) to Sirolimus(SRL)-Based Immunosuppressive Regimen in Kidney Transplant Recipients: 1 Year Results
    Tedesco, H.
    Garcia, V
    Neto, E. D.
    Carvalho, D.
    Contieri, F.
    Abbud, M.
    Pestana, J. O. M.
    TRANSPLANTATION, 2012, 94 (10) : 985 - 985
  • [38] Planned Randomized Conversion From Tacrolimus to Sirolimus-Based Immunosuppressive Regimen in De Novo Kidney Transplant Recipients
    Silva, H. T., Jr.
    Felipe, C. R.
    Garcia, V. D.
    Neto, E. D.
    Filho, M. A.
    Contieri, F. L. C.
    de Carvalho, D. D. B. M.
    Pestana, J. O. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (12) : 3155 - 3163
  • [39] Impact on renal function in kidney transplant recipients with cyclosporine/tacrolimus toxicity after conversion to sirolimus.
    Kashif, WU
    Hariharan, S
    Siddiqi, NA
    Bresnahan, BP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 771A - 772A
  • [40] Efficacy and Safety of Combination Therapy With Tacrolimus and Sirolimus in Immunological High Risk Kidney Transplant Recipients
    Lee, J.
    Kim, B.
    Lee, J.
    Lee, J.
    Choi, G.
    Kim, M.
    Kim, Y.
    Park, K.
    Huh, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 454 - 454
12345